Indication

Vitamin K deficiency induced hypoprothrombinemia

Vitamin K deficiency–induced hypoprothrombinemia is an acquired coagulopathy characterized by pathologically reduced levels of functional prothrombin (coagulation factor II) and other vitamin K–dependent clotting factors. Read more about Vitamin K deficiency induced hypoprothrombinemia

30 drugs 23 manufacturers

Advertisement

Drugs that treat it

Common Vitamin K deficiency induced hypoprothrombinemia therapies.

Showing 10–18 of 30 drugs

Filter & compare in the drug finder →Opens the drug finder with Vitamin K deficiency induced hypoprothrombinemia preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Vitamin K deficiency induced hypoprothrombinemia.

Vitamin K deficiency–induced hypoprothrombinemia is an acquired coagulopathy characterized by pathologically reduced levels of functional prothrombin (coagulation factor II) and other vitamin K–dependent clotting factors.

Affecting the hematologic system, it can develop in neonates due to limited transplacental transfer and low hepatic reserves, or across pediatric and adult populations secondary to severe malnutrition, fat malabsorption disorders, biliary obstruction, or broad-spectrum antibacterial therapy.

Pathophysiologically, insufficient vitamin K impairs the essential hepatic gamma-carboxylation required to synthesize biologically active clotting factors, leading to prolonged prothrombin time, elevated international normalized ratio (INR), and a heightened risk of mucocutaneous, gastrointestinal, or life-threatening hemorrhage.

Personalize your experience

Follow Vitamin K deficiency induced hypoprothrombinemia and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it